Roostaeian Jason, Yoon Alfred P, Rahgozar Paymon, Tanna Neil, Crisera Christopher A, Da Lio Andrew L, Festekjian Jaco H
University of California Los Angeles, Division of Plastic & Reconstructive Surgery, Los Angeles, CA 90095, USA.
University of California Los Angeles, Division of Plastic & Reconstructive Surgery, Los Angeles, CA 90095, USA.
J Plast Reconstr Aesthet Surg. 2015 Apr;68(4):e71-9. doi: 10.1016/j.bjps.2015.01.010. Epub 2015 Jan 26.
Millions of women have undergone augmentation mammaplasty with implants and breast cancer continuing to be the most common non-cutaneous malignancy in female patients. Reconstructive surgeons will inevitably encounter breast cancer patients with prior augmentation. Implant-based techniques represent the most common form of breast reconstruction overall and remains a common option among those who were previously augmented.
The purpose of this study is to evaluate outcomes of implant-based reconstruction in previously augmented women.
A retrospective review from September 2004 to December 2009 was performed. 38 women (63 breasts) with a history of prior augmentation (PA) who underwent implant-based reconstruction were identified and compared to a non-prior augmented (NPA) control group (77 patients; 138 breasts). Normative data, augmentation details, reconstruction method, complication rates, and revision rates were evaluated.
The total complication rate was significantly different between the two groups with 18 complications (28.6%) occurring in 9 PA breasts and 20 complications (14.5%) in 19 NPA breasts (p-value 0.037). When analyzed by specific complication subtypes, capsular contracture was the only complication that bordered significance between the two cohorts (p-value 0.057). Complication rates were otherwise similar regardless of augmentation or reconstruction type.
Implant-based reconstruction is a safe option for previously augmented patients that is able to provide outcomes similar to non-augmented patients. Results are not affected by the location of previous implants or the implant-based reconstruction method. There may be a higher incidence of capsular contracture in the previously augmented patient that warrants further investigation and preoperative discussion.
数以百万计的女性接受了植入式隆胸手术,而乳腺癌仍然是女性患者中最常见的非皮肤恶性肿瘤。重建外科医生不可避免地会遇到曾接受隆胸手术的乳腺癌患者。基于植入物的技术是整体乳房重建中最常见的形式,并且仍然是那些曾接受隆胸手术的患者的常见选择。
本研究的目的是评估曾接受隆胸手术的女性基于植入物的重建效果。
进行了一项回顾性研究,时间跨度为2004年9月至2009年12月。确定了38名有隆胸史(PA)且接受基于植入物重建的女性(63个乳房),并与未接受过隆胸的(NPA)对照组(77名患者;138个乳房)进行比较。评估了标准数据、隆胸细节、重建方法、并发症发生率和翻修率。
两组的总并发症发生率有显著差异,9个PA乳房出现18例并发症(28.6%),19个NPA乳房出现20例并发症(14.5%)(p值0.037)。按特定并发症亚型分析时,包膜挛缩是两组之间唯一接近显著差异的并发症(p值0.057)。无论隆胸或重建类型如何,其他并发症发生率相似。
基于植入物的重建对于曾接受隆胸手术的患者是一种安全的选择,能够提供与未隆胸患者相似的效果。结果不受先前植入物位置或基于植入物的重建方法的影响。曾接受隆胸手术的患者中包膜挛缩的发生率可能较高,值得进一步研究和术前讨论。